Provided by Tiger Trade Technology Pte. Ltd.

Gritstone Oncology Inc.

0.0322
0.0000
Volume:- -
Turnover:2.20M
Market Cap:3.80M
PE:-0.03
High:0.0322
Open:0.0322
Low:0.0322
Close:0.0322
52wk High:3.17
52wk Low:0.0322
Shares:118.11M
Float Shares:115.44M
Volume Ratio:- -
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.0774
EPS(LYR):-1.1988
ROE:-201.94%
ROA:-46.71%
PB:0.17
PE(LYR):-0.03

Loading ...

Gritstone bio Takes Action to Preserve Value and Strengthen Capital Structure

THOMSON REUTERS
·
Oct 10, 2024

Gritstone bio Shares Down 24.3% at $0.15 Premarket After Co Files for Chapter 11 Bankruptcy

THOMSON REUTERS
·
Oct 10, 2024

BRIEF-Gritstone Bio Inc Files For Chapter 11 Bankruptcy - Court Filing

Reuters
·
Oct 10, 2024

Gritstone bio Inc Files for Chapter 11 Bankruptcy - Court Filing

THOMSON REUTERS
·
Oct 10, 2024

Gritstone bio Lists Both Estimated Assets & Liabilities at $100 Mln to $500 Mln- Court Filing

THOMSON REUTERS
·
Oct 10, 2024

Gritstone bio Inc : B. Riley Cuts to Neutral From Buy

THOMSON REUTERS
·
Oct 02, 2024

Gritstone bio Inc : Jonestrading Cuts to Hold From Buy

THOMSON REUTERS
·
Oct 02, 2024

B. Riley Downgrades Gritstone bio to Neutral From Buy, $1 Price Target; Shares Plummet

MT Newswires Live
·
Oct 02, 2024

Gritstone bio Cut to Neutral From Buy by HC Wainwright & Co.

Dow Jones
·
Oct 02, 2024

Gritstone Bio Explores Strategic Alternatives, Analyst Downgrades Ensue -- Shares Fall

MT Newswires Live
·
Oct 02, 2024

HC Wainwright Downgrades Gritstone bio to Neutral From Buy, Adjusts Price Target to $0.50 From $4

MT Newswires Live
·
Oct 01, 2024

Gritstone bio Shares Fall 20.6% After Co Reports Interim Results From Mid-Stage Cancer Study

THOMSON REUTERS
·
Oct 01, 2024

Gritstone bio Shares Fall 16.4% Premarket After Co Reports Interim Results From Mid-Stage Cancer Study

THOMSON REUTERS
·
Oct 01, 2024

BUZZ-Gritstone bio falls after interim results from mid-stage cancer study

Reuters
·
Oct 01, 2024

Gritstone bio, Inc. : H.c. Wainwright Cuts Target Price to $0.5 From $4

THOMSON REUTERS
·
Oct 01, 2024

JMP Securities Downgrades Gritstone bio to Market Perform From Outperform

MT Newswires Live
·
Oct 01, 2024

BRIEF-Gritstone Bio Announces Interim Phase 2 Data For Individualized Neoantigen Targeting Immunotherapy In Colorectal Cancer

Reuters
·
Oct 01, 2024